3M profit beats estimates on healthcare product boost
[BENGALURU] US industrial conglomerate 3M Co topped Wall Street estimates for quarterly profit on Tuesday, as the maker of N95 masks benefited from robust demand for its healthcare products during the Covid-19 pandemic.
There has been a recovery from last quarter when the company suffered a plunge in sales, as demand for office supplies declined with more people working from home due to the pandemic.
The company said the third quarter benefited from strong demand for personal safety and home improvement products.
Sales in its healthcare unit, which also makes surgical supplies and dental products, jumped 25.5 per cent, and accounted for more than a quarter of the company's total sales.
However, the company said end markets for healthcare and oral care elective procedures continued to post year-on-year declines, mainly hit by the pandemic.
Sales at 3M's transportation and electronics division, which also sells auto parts, fell 7.4 per cent.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Net income attributable to 3M fell to US$1.41 billion, or US$2.43 per share, in the third quarter ended Sept 30, from US$1.58 billion, or US$2.72 per share, a year earlier.
Net sales rose 4.5 per cent to US$8.35 billion.
Analysts on average had expected quarterly earnings of US$2.26 per share on revenue of US$8.32 billion, according to Refinitiv data.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Bubble tea maker Chabaidao slumps 10% in Hong Kong’s biggest 2024 debut
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife directors file court application against company to cancel private placement